We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug News
Trending
Commercial Operations
GMPs
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Drug Weekly
FDAnews
Device News
Trending
Commercial Operations
FDA Enforcement Actions
Inspections and Audits
Postmarket Safety
Quality
Regulatory Affairs
Research and Development
Submissions and Approvals
FDAnews Device Weekly
FDAnews
Books
FDAnews Books Library
Drug Books
Device Books
Training/Events
Webinar Training Pass
Events
Webinar Recordings
Resources
Form 483s Database
FDA Approved Drugs
CenterWatch
About Us
The Company
FDAnews Editorial Board
Contact Us
Advertising
Sign In
Create Account
Sign Out
My Account
Home
»
Store
» Commercial Operations
Search the Store
Shop By Category
Drug Products
Drug Books
Device Products
Device Books
Clinical Products
Shop By Media
Books
Webinar Recordings
Commercial Operations
-- Sort By --
New Arrivals
Best Sellers
Price: Low to High
Price: High to Low
A to Z
Par Wins Reprieve From Appeals Court in Patent Fight to Protect AIDS Drug
Price:
$40.00
Learn More
GPhA, Health Groups Argue Leaked TPP Draft Hinders Generic Competition
Price:
$40.00
Learn More
Actavis Barred From Pulling Older Namenda Formulation
Price:
$40.00
Learn More
Jury Favors AstraZeneca and Ranbaxy in Nexium Pay-for-Delay Case
Price:
$40.00
Learn More
PTO Board Upholds First Brand Patent in Generics Challenge
Price:
$40.00
Learn More
Sandoz’s Preemptive Biosimilar Bid Against Amgen’s Enbrel Dismissed
Price:
$40.00
Learn More
Tufts Pegs CROs, Cancer, Trial Design Hottest Trends of 2015
Price:
$25.00
Learn More
China Agrees to Reforms to Speed Innovative Drugs to Market
Price:
$40.00
Learn More
UK Lags Behind Other Countries In Adopting New Meds: Report
Price:
$40.00
Learn More
USTR Review of India’s IP Rights to Focus Largely on Pharma
Price:
$40.00
Learn More
Pharma Exclusivity Could Be Sticking Point on Trans-Pacific Partnership Pact
Price:
$40.00
Learn More
China Fines GlaxoSmithKline $490 Million for Bribery
Price:
$40.00
Learn More
Previous
1
2
…
20
21
22
23
24
25
26
27
28
Next